Company Results

Varvee Global reported a net profit of Rs. 5.34 crore for the third quarter, alongside a sharp doubling of revenue, reflecting strong execution and expanding market reach. The performance highlights the company’s ability to scale operations while maintaining profitability in a competitive environment. Higher volumes, improved customer traction, and better capacity utilization contributed to the robust top-line growth.

Kamdhenu reported a 7 percent year-on-year increase in net profit for the third quarter, with earnings rising to Rs. 21 crore. The performance was supported by stable demand across its core product segments and disciplined cost management amid a challenging operating environment. While input cost volatility and competitive pressures persisted, the company’s focus on brand-led growth and operational efficiency helped sustain profitability. The results highlight Kamdhenu’s ability to navigate market fluctuations while maintaining steady financial momentum in a cyclical industry.

Zuari Industries posted a net loss of Rs. 26.42 crore for the third quarter, reflecting continued pressure on its operating performance across key business segments. The results underscore the challenges facing diversified industrial groups amid volatile input costs, uneven demand conditions, and margin compression. While certain segments showed resilience, overall profitability was weighed down by higher expenses and subdued earnings momentum.

Anupam Rasayan India reported a 12 percent increase in profit for the third quarter, supported by higher revenue and steady demand across key customer segments. The performance highlights the company’s resilience amid a challenging global chemicals environment marked by pricing pressures and cautious customer spending. Improved order execution, a diversified product portfolio, and a focus on value-added specialty chemicals contributed to the earnings growth.

Southern Petrochemical Industries Corporation, widely known as SPIC, reported a profit after tax of Rs. 54.07 crore for the third quarter, reflecting improved operational performance and tighter cost management. The results mark a notable turnaround compared with periods of volatility seen across the fertilizer and chemicals sector. Stable demand, better capacity utilization, and disciplined financial controls supported earnings during the quarter.

India’s capital markets regulator has approved initial public offering (IPO) proposals from five companies, including Premier and Duroflex, paving the way for fresh fundraising activity in the primary market. The approvals indicate renewed issuer confidence amid improving market sentiment and steady retail participation. With equity markets stabilizing and liquidity conditions supportive, companies across manufacturing and consumer segments are tapping public markets to finance expansion and deleverage balance sheets.

GMR Airports reported a decline in net profit for the third quarter, with earnings falling to Rs. 174 crore, reflecting mounting cost pressures and a challenging operating environment. While passenger traffic across key airports remained resilient, higher expenses linked to operations, financing, and infrastructure expansion weighed on the bottom line. The results underscore the delicate balance airport operators face between scaling capacity to meet long-term demand and managing near-term profitability.

Fortis Healthcare reported a 22% year-on-year decline in net profit to Rs 197 crore for the third quarter, reflecting margin pressures and higher operating costs despite stable patient volumes. The hospital chain faced elevated input expenses and normalization effects following a strong prior-year performance. While revenues remained resilient, profitability was tempered by rising manpower costs and investment in clinical infrastructure. Analysts suggest the earnings dip highlights the sector’s sensitivity to cost inflation and competitive intensity.

Akums Drugs & Pharmaceuticals reported a 29.5% year-on-year increase in net profit to Rs 86 crore for the third quarter, driven by robust demand across domestic formulations and contract manufacturing services. The earnings growth reflects improved operating leverage, efficient cost management and steady order inflows from branded pharmaceutical clients. As India’s contract development and manufacturing organization (CDMO) segment gains traction globally, Akums appears to be benefiting from scale efficiencies and diversified product capabilities.

EID Parry (India) Ltd reported a net profit of Rs 437 crore for the third quarter, reflecting improved realizations in its sugar business and stable growth in its nutraceuticals segment. The earnings expansion highlights the company’s diversified revenue model and operational efficiency amid fluctuating commodity cycles. Higher sugar prices, disciplined cost management and resilient demand contributed to margin improvement during the quarter.